Access cutting-edge fatty liver disease treatment through this clinical trial at a research site in Peoria. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Peoria location
Preparing your pre-screening questions…
Access fatty liver disease specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related fatty liver disease treatment provided free
Check if you qualify for this fatty liver disease clinical trial in Peoria, AZ
No-Cost Study Care
Local to Peoria
Convenient for AZ residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The main purpose of the SYNERGY-OUTCOMES study is to find out whether retatrutide and tirzepatide can prevent major adverse liver outcomes (MALO) in people with high-risk metabolic dysfunction-associated steatotic liver disease (MASLD). The study will enroll adults who have MASLD based on non-invasive tests (NITs), which indicate they are more likely to develop MALO. Participants will be randomly assigned within a Master Protocol to receive either retatrutide (N1T-MC-RT01), tirzepatide (N1T-MC-T
Sponsor: Eli Lilly and Company
Yes, this clinical trial (NCT07165028) has an active research site in Peoria, AZ that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for fatty liver disease treatment options in Peoria, AZ, this clinical trial (NCT07165028) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Peoria research site is actively enrolling participants for this clinical trial. You'll receive care from experienced fatty liver disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all fatty liver disease clinical trials near you to find additional studies recruiting in your area.
See all ankylosing spondylitis clinical trials recruiting in Peoria — not just this study.
Browse Ankylosing Spondylitis Trials in Peoria →